Microalbuminuria predicts mortality in non-insulin-dependent diabetics

scientific article published on 01 May 1984

Microalbuminuria predicts mortality in non-insulin-dependent diabetics is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1464-5491.1984.TB01915.X
P698PubMed publication ID6242771

P2093author name stringG C Viberti
R J Jarrett
T J Murrells
R D Hill
A Argyropoulos
U Mahmud
P433issue1
P304page(s)17-19
P577publication date1984-05-01
P1433published inDiabetic MedicineQ15758639
P1476titleMicroalbuminuria predicts mortality in non-insulin-dependent diabetics
P478volume1

Reverse relations

cites work (P2860)
Q39236326'Microalbuminuria' and diabetes: a critique--assessment of urinary albumin excretion and its role in screening for diabetic nephropathy
Q44940887'Microalbuminuria' in type I (insulin-dependent) diabetic patients with and without retinopathy
Q72249253A charge selectivity impairment in protein permselectivity is present in type 2 diabetes
Q41332341ACE inhibitors and proteinuria
Q68365130Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion
Q71564790Albumin excretion and vascular deaths in NIDDM
Q51025301Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy.
Q67901191Albuminuria and associated medical risk factors: A cross-sectional study in 451 type II (noninsulin-dependent) diabetic patients. Part 2
Q43628515Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians
Q38672988Albuminuria reflects widespread vascular damage. The Steno hypothesis.
Q37412684Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?
Q35642519Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications
Q24803174An interaction between the interleukin-6 -174G>C gene variant and urinary protein excretion influences plasma oxidative stress in subjects with type 2 diabetes
Q35766610Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. The Melbourne Diabetic Nephropathy Study Group
Q40754772Antiplatelet agents in the prevention of diabetic vascular complications.
Q37096470Are Conventional Risk Factors for Mortality Relevant in Type 2 Diabetes?
Q70989583Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics
Q71293195Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM
Q44235869Blood Rheology and Cardiovascular Risk Factors in Type 1 Diabetes: Relationship with Microalbuminuria
Q77579335Calcium antagonists and cardiovascular risk in diabetes
Q43859914Cardio vascular morbidity in proteinuric south Indian NIDDM patients
Q33843624Cardiovascular disease in diabetic patients
Q62113326Cardiovascular mortality in non-insulin-dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects
Q39748118Clinical diabetic nephropathy: natural history and complications
Q67822063Clinical significance of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes
Q36597794Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes.
Q44157415Comparison of early renal dysfunction in type I and type II diabetes: differing associations with blood pressure and glycaemic control
Q68325939Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients
Q69022404Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors
Q35627938Cost-effective strategies in the prevention of diabetic nephropathy
Q34053578Danish general practitioners' estimation of urinary albumin concentration in the detection of proteinuria and microalbuminuria.
Q59150879Determinants of end-stage renal disease in Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus and proteinuria
Q37079790Diabetes and Arterial Disease
Q41563034Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention
Q33883966Diabetic nephropathy. Prevention and early referral
Q41094725Diabetic vascular injury and ACE. Potential for pharmacological prevention of complications of later life
Q33815573Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure
Q35576079Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease
Q72877433Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus?
Q36456306Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).
Q69311611Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats
Q68028511Eight to nine year mortality in known non-insulin dependent diabetics and controls
Q73936725Elevated urinary albumin excretion is not linked to the angiotensin I-converting enzyme gene polymorphism in clinically healthy subjects
Q44178748Epidemiologic study of type 2 diabetes in Taiwan
Q41388533Epidemiology of non-insulin-dependent diabetes mellitus and its macrovascular complications. A basis for the development of cost-effective programs
Q36756205Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark
Q42494570Features of endothelial dysfunction in early diabetic nephropathy
Q33400488Glomerular endothelium: a porous sieve and formidable barrier.
Q40781789Glomerulosclerosis in type 2 (non-insulin-dependent) diabetes mellitus: relationship to glycaemia in the University Group Diabetes Program (UGDP).
Q70266880Hypertension
Q41263538Hypertension in diabetes mellitus.
Q27004016Impact of microalbuminuria on incident coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis of prospective studies
Q36896206Impaired aerobic work capacity in insulin dependent diabetics with increased urinary albumin excretion
Q43709282Impaired autoregulation of the retinal vasculature and microalbuminuria in diabetes mellitus
Q83104034Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease
Q36264790Incidence of microalbuminuria in tobacco chewers
Q74100672Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men
Q74578663Initial urinary albumin excretion determines the progression of microalbuminuria in patients with type-2 diabetes and normotensive blood pressure values despite improved metabolic control
Q51590370Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.
Q50936894Insulin resistance in non-obese, non-insulin-dependent diabetic patients with diabetic nephropathy.
Q43638278Insulin resistance precedes the appearance of albuminuria in non-diabetic subjects: 6 years follow up study
Q51599898Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Q38598332Interventions based on microalbuminuria screening and low-protein diet in the treatment of kidney disease of diabetes mellitus
Q33852450Is it possible to predict diabetic kidney disease?
Q44498867Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study
Q69782467Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment
Q61328730Long-term effects of amlodipine versus fosinopril on microalbuminuria in elderly hypertensive patients with type 2 diabetes mellitus
Q72651968Long-term glycemic control and the rate of progression of early diabetic kidney disease
Q41689300Markers of diabetic nephropathy
Q35163137Metabolic acidosis-induced insulin resistance and cardiovascular risk
Q68032081Microalbuminuria
Q36255435Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?
Q36683530Microalbuminuria and coronary heart disease in non-diabetics
Q35197102Microalbuminuria and diabetic cardiovascular disease
Q44064903Microalbuminuria and intima-media thickness of the carotid artery in clinically healthy men.
Q39762088Microalbuminuria as a predictor of clinical diabetic nephropathy
Q35167321Microalbuminuria as predictor of increased mortality in elderly people
Q41914147Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey
Q70768900Microalbuminuria does not predict cardiovascular disease in a normal general practice population
Q73498928Microalbuminuria in Patients with Non-Insulin-dependent Diabetes Mellitus Relates to Nocturnal Systolic Blood Pressure
Q39404247Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area
Q33786866Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications
Q34381747Microalbuminuria in inflammatory bowel disease
Q36683095Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy
Q36894762Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients
Q33564421Microalbuminuria in systemic sclerosis
Q34825007Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy
Q50960655Microalbuminuria is not associated with cardiovascular death in Japanese NIDDM.
Q45295195Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients
Q40431039Microalbuminuria: Prognostic and Therapeutic Implications in Diabetic and Hypertensive Pregnancy
Q52875754Microproteinuria in Type 2 Diabetes Mellitus from Diagnosis
Q33788444Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid?
Q50920620NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.
Q40846304Nephropathy and hypertension in diabetes
Q36683483Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM).
Q41104987Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria
Q43155243Predictive value of microalbuminuria in longstanding insulin dependent diabetes
Q36600524Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
Q61948450Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients
Q53771713Prevalence of microalbuminuria in maturity onset primarily non-insulin-requiring diabetes mellitus: effect of disease duration, glycemic control, and mean systemic blood pressure.
Q36894434Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes.
Q33608889Prevalence of microalbuminuria, lipoprotein (a) and coronary artery disease in the lipid clinic
Q36648858Preventing microalbuminuria in patients with type 2 diabetes
Q40923073Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Q40415958Prevention of diabetic renal disease with special reference to microalbuminuria
Q32135671Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria.
Q44209360Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study
Q72616614Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment
Q46090183Progression of overt nephropathy in non-insulin-dependent diabetes
Q57740575Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study
Q33892174Proteinuria: its clinical importance and role in progressive renal disease.
Q34070807Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus
Q95811363Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity
Q37048431Relationship between diabetic dyslipoproteinaemia and coronary heart disease risk in subjects with non-insulin-dependent diabetes mellitus
Q46505819Relationship of elevated urinary albumin excretion to components of the metabolic syndrome in non-insulin-dependent diabetes mellitus.
Q50605232Relationship of progressively increasing albuminuria to apoprotein(a) and blood pressure in type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetic patients.
Q72616634Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria
Q40781800Renal function changes in middle-aged and elderly Caucasian type 2 (non-insulin-dependent) diabetic patients--a review
Q41431044Renal mortality associated with non-insulin-dependent diabetes mellitus
Q44070281Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy
Q70109628Risk of nephropathy in diabetes mellitus: problems of methodology and terminology
Q54440004Screening for Microalbuminuria in Type 2 Diabetic Patients: the Evaluation of a Dipstick Test in General Practice
Q37124877Screening for Microalbuminuria: Which Measurement?
Q73795277Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model
Q46700898Sodium-lithium countertransport is associated with insulin resistance and urinary albumin excretion in young African-Americans
Q72616733Storage temperature and differing methods of sample preparation in the measurement of urinary albumin
Q72679449Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects
Q41431039The Deidesheimer meeting: significance of classical and new risk factors in non-insulin-dependent diabetes mellitus
Q68234601The Prevalence of Hypercholesterolaemia and its Relationship With Albuminuria in Insulin-dependent Diabetic Patients: An Epidemiological Study
Q70760004The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Q77926908The changes of lacunar state during a 5-year period in NIDDM
Q34200394The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus
Q36024390The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate
Q56945006The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabetics
Q39748109The kidney in diabetes: significance of the early abnormalities
Q39610361The long-term care of non-insulin-dependent diabetes
Q35715065The management of diabetic proteinuria. Which antihypertensive agent?
Q35087669The meaning of microalbuminuria in type 1 diabetes: the need for a new paradigm
Q39578357The natural history of non-insulin-dependent diabetes mellitus
Q72258292The relationship of urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM
Q72616618Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients
Q70495327UK Prospective Diabetes Study (UKPDS). IX: Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy
Q67834120UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance
Q72616609UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia
Q38492248Update on blood pressure control and renal outcomes in diabetes mellitus
Q71993556Urinary Albumin Excretion in a Population Based Cohort
Q51585793Urinary albumin excretion rate and 24-h ambulatory blood pressure in NIDDM with microalbuminuria: effects of a monounsaturated-enriched diet.
Q51577626Urinary albumin excretion rate is related to insulin resistance in normotensive subjects with impaired glucose tolerance.
Q73484892Use of urine specific gravity to improve screening for albuminuria
Q73526387Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group
Q44976642Vascular risk factors in Japanese non-insulin-dependent diabetic patients with microalbuminuria
Q68055622Vectorcardiographic evaluation of diabetic cardiomyopathy and of its contributing factors
Q84333398[Diabetic nephropathy and cardiovascular risk]

Search more.